SM
Therapeutic Areas
Ceribell Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ceribell System with Clarity® | Detection of Non-Convulsive Seizures & Status Epilepticus | FDA Cleared |
| Ceribell System | Delirium Monitoring | Development |
| Clarity Algorithm v6 | Seizure Detection & Burden Quantification | FDA Cleared |
| Future AI Algorithms | Neurological Conditions Beyond Seizures | Research |
Leadership Team at Ceribell
JC
Jane Chao, PhD
President, Chief Executive Officer, Co-Founder, and Director
RW
Raymond Woo, PhD
Chief Technology Officer
SB
Scott Blumberg
Chief Financial Officer
LD
Louisa Daniels
General Counsel
PV
Paul Vespa, MD
Neurologist & Neurocritical Care (UCLA) - Featured Clinician
LG
Laleh Gharahbaghian, MD
ED Physician (Stanford Health Care) - Featured Clinician
MK
Mary Kay Bader, CCRN, CNRN
Nurse (Mission Hospital) - Featured Clinician
MB
Margo Block, DO
Neurologist (University of Kansas Medical Center) - Featured Clinician
DO
Daiwai Olson, PhD
Nurse (UT Southwestern) - Featured Clinician
PD
Parshaw Dorriz, MD
Neurologist (Mission Hospital) - Featured Clinician